The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

• The objective of this guidebook is to facilitate the implementation of standardized health
labour market analysis (HLMA) approaches to help countries answer key policy questions …

Endemic infection with the human T cell leukemia/lymphoma viruses I and II (HTLV-I/II) is
now recognized to be worldwide, and is becoming epidemic among intravenous drug …

Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a
number of American Indian populations, and high rates of infection have also been …

Human T-cell lymphotropic virus (HTLV) type I (HTLV-I) is the etiological agent of adult T-cell
leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV …

Molecular studies have demonstrated the existence of at least two major subtypes of human
T-cell lymphotropic virus type 2 (HTLV-2), designated HTLV-2a and HTLV-2b. To further …

For 4 years, we determined the mode and risk of mother-to-child transmission of HTLV-I in a
prospective cohort of 34 children born to seropositive mothers in Franceville, Gabon. We …

A commonly held theory is that the first wave of migrants into the New World was derivative
from the ethnic groups then inhibiting eastern Siberia. However, these ethnic groups lack a …

Objectives Human T‐lymphotropic virus (HTLV)‐1 causes T‐cell leukaemia and myelopathy.
Together with HTLV‐2, it is endemic in some African nations. Seroprevalence data from …